FindTrial
Sign In

The effects of stellate ganglion block on sleep quality and daytime higher cognitive function of sleep disorders

The effects of stellate ganglion block on sleep quality and daytime higher cognitive function of sleep disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014274
Enrollment
Unknown
Registered
2018-01-02
Start date
2018-01-15
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders

Interventions

Group A:ultrasound guided stellate ganglion block injecting 0.2 ropivacaine 10ml
Group B:ultrasound guided stellate ganglion block injecting NS

Sponsors

Dept. of Anaesthesiology, Fujian Provincial Hospital Jinshan branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic standards of insomnia disorders, American diagnostic and statistical manual of mental disorders (fifth edition); 2. Not been treated; 3. Sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic reaction to the anesthesia; 2. asthmatic; 3. There is a tendency of bleeding; 4. Patients with snoring or sleep apnea syndrome.

Design outcomes

Primary

MeasureTime frame
sleep quality; higher cognitive function;—

Countries

China

Contacts

Public ContactYanqing Chen

Dept. of Anaesthesiology, Fujian Provincial Hospital Jinshan branch

sxd605@163.com+86 13314935073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026